EGFR and neoplasm: Aside from the tumour which exhibited the APOBEC-like mutation signature, in our cohort, a high percentage of MIAs and LPAs were EGFR mutant, which may explain why the number of somatic mutations is low and no difference in tumour mutational burden was found between two groups.